title: Protein disulfide isomerase as an antithrombotic target.
abstract: Protein disulfide isomerase (PDI) is a ubiquitously expressed oxidoreductase required for proper protein folding. It is highly concentrated in the endoplasmic reticulum, but can also be released into the extracellular environment. Several in vivo thrombosis models have demonstrated that vascular PDI secreted by platelets and endothelial cells is essential for normal thrombus formation. Inhibition of extracellular PDI thus represents a potential strategy for antithrombotic therapy. Yet this approach requires the discovery of well-tolerated PDI inhibitors. A recent high-throughput screening identified the commonly ingested flavonoid, quercetin-3-rutinoside, as an inhibitor of PDI. Quercetin-3-rutinoside blocked thrombus formation at concentrations that are commonly ingested as nutritional supplements. The observation that a compound with Generally Recognized As Safe status inhibits PDI and blocks thrombosis in animal models forms a rationale for clinical trials evaluating PDI inhibitors as a new class of antithrombotics.
authors.affiliation: Division of Hemostasis and Thrombosis, Department of Medicine, BIDMC, Harvard Medical School, Boston, MA, USA. Electronic address: rflaumen@bidmc.harvard.edu.
authors.forename: Robert
authors.initials: R
authors.lastname: Flaumenhaft
mesh_terms: D000818:Animals; D001792:Blood Platelets / Q000378:metabolism; D055808:Drug Discovery; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D042783:Endothelial Cells / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D008955:Models, Cardiovascular; D019704:Protein Disulfide-Isomerases / Q000037:antagonists & inhibitors / Q000378:metabolism; D012431:Rutin / Q000494:pharmacology*; D013927:Thrombosis / Q000188:drug therapy / Q000378:metabolism
chemical_list: D005343:Fibrinolytic Agents; D012431:Rutin; D019704:Protein Disulfide-Isomerases
references.citation: Arch Intern Med. 1999 Oct 11;159(18):2170-4
references.pmid: 10527294
references.citation: Blood. 1995 Sep 15;86(6):2168-73
references.pmid: 7662965
references.citation: Biochem Biophys Res Commun. 2000 Jul 14;273(3):829-32
references.pmid: 10891332
references.citation: Biochemistry. 2001 May 22;40(20):6070-5
references.pmid: 11352743
references.citation: Blood. 2003 Sep 15;102(6):2085-92
references.pmid: 12791669
references.citation: J Leukoc Biol. 2009 Oct;86(4):989-98
references.pmid: 19564574
references.citation: Am J Clin Nutr. 2012 Feb;95(2):454-64
references.pmid: 22218162
references.citation: Blood. 1992 May 1;79(9):2226-8
references.pmid: 1571538
references.citation: Blood. 2005 Feb 15;105(4):1500-7
references.pmid: 15466936
references.citation: Blood. 2010 Nov 25;116(22):4665-74
references.pmid: 20668226
references.citation: Free Radic Biol Med. 2004 Apr 1;36(7):829-37
references.pmid: 15019968
references.citation: Blood. 2012 Jul 19;120(3):647-55
references.pmid: 22653978
references.citation: J Autoimmun. 2012 Sep;39(3):121-9
references.pmid: 22704541
references.citation: Proteomics. 2005 Nov;5(17):4398-413
references.pmid: 16222722
references.citation: J Clin Invest. 2008 Mar;118(3):1123-31
references.pmid: 18292814
references.citation: J Thromb Haemost. 2012 Feb;10(2):278-88
references.pmid: 22168334
references.citation: Thromb Res. 2012 May;129 Suppl 2:S11-2
references.pmid: 22401798
references.citation: Br J Haematol. 1999 Mar;104(3):448-54
references.pmid: 10086777
references.citation: Cardiol Clin. 2008 May;26(2):277-88, vii
references.pmid: 18407000
references.citation: Proc Natl Acad Sci U S A. 1993 May 1;90(9):4112-6
references.pmid: 8387210
references.citation: J Clin Invest. 2008 Mar;118(3):1110-22
references.pmid: 18274674
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16348-53
references.pmid: 22988091
references.citation: Am J Clin Nutr. 2002 May;75(5):880-6
references.pmid: 11976162
references.citation: Thromb Res. 1999 Dec 15;96(6):445-50
references.pmid: 10632467
references.citation: Biochim Biophys Acta. 2008 Apr;1783(4):535-48
references.pmid: 18093543
references.citation: J Cell Biol. 2012 Aug 20;198(4):561-74
references.pmid: 22908309
references.citation: J Biol Chem. 2000 Mar 31;275(13):9758-66
references.pmid: 10734129
references.citation: J Clin Invest. 2012 Jun;122(6):2104-13
references.pmid: 22565308
references.citation: ACS Chem Biol. 2011 Mar 18;6(3):245-51
references.pmid: 21121641
references.citation: Biochemistry. 2006 Oct 3;45(39):12020-8
references.pmid: 17002301
references.citation: Cancer Res. 2008 Jul 1;68(13):5363-9
references.pmid: 18593938
references.citation: Br J Haematol. 2010 Feb;148(4):627-37
references.pmid: 19995400
references.citation: Blood. 2012 Feb 16;119(7):1737-46
references.pmid: 22207737
references.citation: J Biomol Screen. 2004 Oct;9(7):614-20
references.pmid: 15475481
references.citation: N Engl J Med. 2004 Jun 17;350(25):2558-63
references.pmid: 15201412